Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Patent Protection
Pharma
Roche's high-dose version of Ocrevus flunks phase 3 trial
Roche had high hopes for its high dose version of multiple sclerosis powerhouse Ocrevus, but a trial of the new formulation has come up short.
Kevin Dunleavy
Apr 2, 2025 3:26pm
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
Drugmakers dig in their heels amid FTC's latest patent crackdown
Jun 25, 2024 9:20am
FTC targets Novo's Ozempic among 300-plus 'junk' patents
May 1, 2024 7:30am
Lawmakers blast Biden administration's 'march-in' proposal
Feb 23, 2024 9:53am
FTC calls for 'expansive and flexible' use of march-in rights
Feb 6, 2024 5:00pm
